ADC Therapeutics Q1 2026 Earnings EPS Beat but No Revenue Reported Stock Slips COYA Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Efficiency Gains GEVO Q1 2026 Earnings Significant EPS Miss Amid Operational Transition LAR Q1 2026 Earnings EPS Misses Estimates as Development Continues APH Q1 2026 Earnings EPS Beats Estimates by 113 Stock Edges Higher CMPR Q1 2026 Earnings Massive EPS Surprise Highlights Profitability Strength